Patent · US Expired

Hyperstabilizing antisense nucleic acid binding agents

USRE38169E1 · kind E1 · reissue

0Cited by
3References
39Claims
0Family size

Assignee

Inventor

Key dates

Filing dateJul 26, 2000
Grant dateJul 1, 2003
Priority date
Expiry dateJul 26, 2020

Classification

  • Technology area (CPC —)General

Abstract

Attaching certain ligands to antisense probes will hyperstabilize sense-antisense duplexes. Such a hyperstabilized duplex is resistant to melting of the strands from one another, to unwinding of the strands, and to the action of nucleases. Applications include antiretroviral action, antireverse-transcriptase action, antiviral action, antiparasitical action, antibacterial action, antifungal action, anticancer action, anti-oncogene action, and other applications where it is desired to inhibit gene expression at the genomic or messenger RNA level. The preferred ligands are certain minor-groove-binding agents, exemplified by CC-1065 and synthetic CC-1065 analogs.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.